Diagnostic Performance of Noninvasive Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography in Suspected Coronary Artery Disease-Reference-Cited by-同舟云学术

Diagnostic Performance of Noninvasive Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography in Suspected Coronary Artery Disease

Published:2014-04 Issue:12 Volume:63 Page:1145-1155
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Nørgaard Bjarne L.,Leipsic Jonathon,Gaur Sara,Seneviratne Sujith,Ko Brian S.,Ito Hiroshi,Jensen Jesper M.,Mauri Laura,De Bruyne Bernard,Bezerra Hiram,Osawa Kazuhiro,Marwan Mohamed,Naber Christoph,Erglis Andrejs,Park Seung-Jung,Christiansen Evald H.,Kaltoft Anne,Lassen Jens F.,Bøtker Hans Erik,Achenbach Stephan

Funder

Abbott Vascular, Boston Scientific, Cordis, Medtronic, HeartFlow, Eli Lilly, Bristol-Myers Squibb, Daiichi Sankyo, and Sanofi-aventis

Siemens, Guerbet, and Abbott

St. Jude Medical, Boston Scientific, Radi, Terumo, and Volcano

GE Healthcare

Edwards Lifesciences

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation;Tonino;J Am Coll Cardiol,2010